Alkem Laboratories has received tentative approval from the US Federal Drug Administration for the generic of Lyrica (Pregabalin) in 75mg, 100mg, 150mg, 200mg, 225mg and 300mg, details on the regulator’s website show. Lyrica is used to treat patients of nerve pain caused by diabetic nerve and spinal cord injury, among other conditions. It is also an anti-epileptic drug. Shares of the company inched up 0.1 per cent at ₹1,675 on the BSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.